Association between alpha‐1‐antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease
- 1 June 2000
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 30 (6) , 543-548
- https://doi.org/10.1046/j.1365-2362.2000.00655.x
Abstract
Background The antiproteases, including alpha‐1‐antitrypsin, are supposed to prevent lungs from becoming emphysematous. Genetic susceptibility to smoking injury may confer a risk for the development...Keywords
This publication has 20 references indexed in Scilit:
- Genetic Epidemiology of Severe, Early-onset Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Genetic risk factors for chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1997
- Evidence-Based Health Policy—Lessons from the Global Burden of Disease StudyScience, 1996
- Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells.Journal of Clinical Investigation, 1995
- The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung diseaseJournal of Hepatology, 1993
- A Leucine-to-Proline Substitution Causes a Defective α1-Antichymotrypsin Allele Associated with Familial Obstructive Lung DiseaseGenomics, 1993
- Alpha‐1 antichymotrypsin is increased in human alveolar macrophages by phorbol myristate acetate or lipopolysaccharide and released from these activated macrophages by glucocorticoidThe Journal of Pathology, 1991
- Differential susceptibility to tobacco smoke: possible mechanismsPharmacogenetics, 1991
- Free-radical chemistry of cigarette smoke and its toxicological implications.Environmental Health Perspectives, 1985
- The natural history of chronic airflow obstruction.BMJ, 1977